McKesson FDA Wednesday, March 12, 2014 +0.20 Positive

FDA Approves LIDOCAINE HYDROCHLORIDE — McKesson Corporation dba SKY Packaging

McKesson Corporation dba SKY Packaging announced the FDA approval of generic lidocaine hydrochloride (ANDA 204494), a topical solution widely used for local anesthesia and mucosal analgesia. This approval solidifies the company's position in the sterile injectable and topical pharmaceuticals market, underscoring its continued role as a major supplier amidst ongoing generic competition.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed